FINDING A CURE

The mission of the Foundation is to fund, promote, and support medical research dedicated to developing treatments and a cure for ML4.

 

FUND OUR RESEARCH

Your donations directly support ML4 researchers at top academic institutions dedicated to finding treatments for Mucolipidosis Type IV.

 

PARTICIPATE IN RESEARCH

ML4 Families are invited to participate in an exciting clinical research study with our partners at Massachusetts General Hospital and Harvard.

 

OUR FAMILIES

The faces of ML4 and the reason for our work

What is ML4?

Mucolipidosis Type IV was first identified as a genetic lysosomal storage disease in 1974. Children with ML4 begin to exhibit developmental delays during the first year of life and many parents often pursue ophthalmologic evaluations for pseudo-strabismus.

Read more here

Our Mission

ML4 is a genetic disease causing developmental delays, retinal degeneration, gross and small motor dysfunction, and limited lifespan. The Foundation’s mission is to fund, support, and promote medical research dedicated to developing treatments and a cure for ML4.

Read more here

Patient Registry

If you or a family member have been diagnosed with ML4 or have not yet received a diagnosis, you are invited to participate in the CoRDS registry. Connect to the exciting science news and receive notifications of research opportunities for which you are eligible!

Read more here